The short version

From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.

  • Covista is the larger company, worth $4.4B, close to Grand Canyon Education's $4.2B.
  • Covista grew revenue faster over the last year (+9.7% vs +6.7%).
  • Grand Canyon Education keeps more of each dollar of revenue as operating profit (24.5% vs 19.6%).
  • On earnings, Covista is the cheaper stock (18.7x vs 19.9x).
  • Grand Canyon Education's price assumes faster free cash flow growth: about 3% a year, against -3% for Covista (reverse DCF).

Side by side

The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.

MeasureCVSALOPE
Market cap$4.4B$4.2B
Share price$129.38$159.80
Revenue (last fiscal year)$2.0B$1.1B
Free cash flow (last fiscal year)$393M$239M
Revenue growth, last year+9.7%+6.7%
Revenue growth per year, last 5 fiscal years+9.0%+5.4%
Operating margin19.6%24.5%
Net margin12.9%19.6%
Return on equity17.4%33.5%
P/E (trailing)18.7x19.9x
Price / free cash flow15.2x17.6x
EV / EBITDA10.8x13.0x
FCF growth the price implies-2.7%3.3%
Dividend yield——
Debt / equity1.08x0.37x
Fundamental gradeBB
Superinvestors holding it43
Insider purchases, last 12 months40

Results from SEC filings

Revenue and free cash flow by fiscal year, from each company's 10-K filings.

Covista

YearRevenueFree cash flowOp. margin
2022$1.4B-$20M5.6%
2023$1.5B$166M11.6%
2024$1.6B$247M13.7%
2025$1.8B$288M19.1%
2026$2.0B$393M19.6%

Grand Canyon Education

YearRevenueFree cash flowOp. margin
2021$897M$284M31.5%
2022$911M$186M26.1%
2023$961M$199M25.9%
2024$1.0B$253M26.7%
2025$1.1B$239M24.0%

Where the revenue comes from

Covista · by segments, 2026

Walden$805M41%
Chamberlain$750M38%
Medical and Veterinary$399M20%

Grand Canyon Education

No segment breakdown reported.

Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open CVSA in Investingly

Questions

Which is bigger, Covista or Grand Canyon Education?

Covista (CVSA), at $4.4B against $4.2B.

Is CVSA or LOPE cheaper?

By trailing P/E, Covista (18.7x) is cheaper than Grand Canyon Education (19.9x). A lower multiple can also mean the market expects less growth.

Which grows faster, CVSA or LOPE?

Covista: revenue grew +9.7% over the last year, against +6.7%.

Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.